Dengue vaccine study seeks clues in immune cells
NCT ID NCT07158190
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 33 times
Summary
This study aims to understand how T-cells (a type of immune cell) respond to the Takeda dengue vaccine. Researchers will analyze blood samples from 30 healthy adults before and after vaccination to identify markers that may predict protection. The goal is to learn more about the immune response, not to test the vaccine's effectiveness directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Policlinico Universtiario Agostino Gemelli IRCCS
Rome, Roma, 00168, Italy
Conditions
Explore the condition pages connected to this study.